1. "Drug Information for Laniazid." Micromedex. June 30, 2000. <http://www.drugs.com/cons/Laniazid.html>.
2. "Isoniazid." American Society of Health-System Pharmacists Inc. Bethesda, Maryland, 2004. <http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a682401.html>.
3. "Product List." Drugstore: Wide choice of medicines from wholesales around the world. <http://hp2ibm.weblogger.com/>.
4. Moore, M. et al. "Trends in drug-resistant tuberculosis in the United States, 1993-1996." The Journal of American Medical Association, Vol. 278 No. 10 Sept. 10, 1997. <http://jama.ama-assn.org/cgi/content/abstract/278/10/833>.
5. "What is TB." Tuberculosis Department of Communicable Diseases. World Health Organization, 2001. <http://w3.whosea.org/tb/tb.htm>.
6. Sharma S.K. et al. "Multidrug-resistant tuberculosis." Indian J Med Res 120 October 2004, pp. 354-376.
7. Moulding, Thomas, et al. "Fixed-Dose Combinations of Antituberculosis medications to prevent drug resistance." Annals of Internal Medicine vol 122 Iss 12, pp. 951-954.
8. Crawford, C. "Toxicity, Isoniazid."emedicine. May 20, 2005. <www.emedicine.com/EMERG/topic287.htm>.
9. Rabassa, Alfredo A. et al. "Isoniazid- induced Pancreatitis." Annals of Internal Medicine vol 121 iss 6 Sept 15, 1994, pp. 433-434.
10. Rom, William N. and Stuart Gray. "Isoniazid: Clinical Use and Toxicity." Tuberculosis. Little Brown and comp. New York, 1996.
11. Rom, William N. and Stuart Gray. "Isoniazid Chemistry, Metabolism, and Mechanism of Action." Tuberculosis. Little Brown and comp. New York, 1996.